Interstitial Lung Disease Autoantibody Panel (Change effective as of 01/21/25: Refer to 3018869 in the January Hotline)

Use

This panel was used prior to January 21, 2025, to help evaluate interstitial lung disease in the context of systemic autoimmune rheumatic disease. It provided detection of multiple autoantibodies associated with connective tissue disease–associated ILD and allowed comprehensive serologic evaluation in a single order.

Not provided.